Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06432582
Status:
RECRUITING
Last Update Posted:
2024-05-29
First Post:
2024-05-16
Brief Title:
hepatomiR cACLD Study
Sponsor:
Karl Landsteiner University of Health Sciences
Organization:
Karl Landsteiner University of Health Sciences
Study Overview
Official Title:
Assessment of a hepatomiR Cut-off for Predicting Specific Hepatic Decompensation Events in Advanced Chronic Liver Disease
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study looks to gather data on hepatomiR a CE-certified test already intended for gauging liver-related outcomes in order to define a cut-off regarding specific decompensation events ascites variceal hemorrhage hepatic encephalopathy in chronic liver disease CLD Based on these data it is aimed to advance the current understanding of factors driving decompensation with potential repercussions for future risk management and therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None